Revenue: The sum of all revenue fields included for a company's operating activities.
BioNexus Gene Lab Corp. (BGLC) had Revenue of $2.26M for the most recently reported fiscal quarter, ending 2025-06-30.
Income Statement Financials | |
Revenue |
$2.26M |
$-0.62M |
|
$1.89M |
|
$0.37M |
|
$2.87M |
|
$-0.61M |
|
$-0.00M |
|
$-0.62M |
|
$-0.62M |
|
$-0.62M |
|
$-0.62M |
|
$-0.62M |
|
$-0.62M |
|
$-0.58M |
|
$-0.54M |
|
1.80M |
|
1.80M |
|
$-0.34 |
|
$-0.34 |
|
Balance Sheet Financials | |
$6.38M |
|
$1.59M |
|
$3.04M |
|
$9.42M |
|
$1.76M |
|
-- |
|
$0.14M |
|
$1.90M |
|
$7.52M |
|
$7.52M |
|
$7.52M |
|
1.80M |
|
Cash Flow Statement Financials | |
$-1.56M |
|
$-0.04M |
|
$-0.00M |
|
$2.89M |
|
$1.54M |
|
$-1.35M |
|
-- |
|
-- |
|
-- |
|
Fundamental Metrics & Ratios | |
3.63 |
|
-- |
|
-- |
|
-- |
|
-- |
|
16.28% |
|
-27.05% |
|
-25.73% |
|
-- |
|
-27.26% |
|
-27.26% |
|
$-1.59M |
|
-- |
|
-- |
|
-- |
|
0.24 |
|
1.56 |
|
1.07 |
|
83.81 |
|
-8.19% |
|
-8.19% |
|
-6.54% |
|
-8.19% |
|
$4.19 |
|
$-0.89 |
|
$-0.87 |